Malignant neoplasm of ovary, including Hilmo

C3_OVARY_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C56 Hospital discharge: ICD-9 — 183 Hospital discharge: ICD-8 — 1830 Cause of death: ICD-10 — C56 Cause of death: ICD-9 — 183 Cause of death: ICD-8 — 1830 Cancer registry: Topography ICD-O-3 — C56 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2777
4. Check minimum number of events None	2777
5. Include endpoints None	2777
6. Filter based on genotype QC (FinnGen only)	2501

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_OVARY_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C56
HD_ICD_9	183
HD_ICD_8	1830
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C56
COD_ICD_9	183
COD_ICD_8	1830
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C56
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of ovary, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2501	2501	-
Unadjusted period prevalence (%)	0.89	0.89	-
Median age at first event (years)	62.17	62.17	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2594: Matched controls
25940

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

51.4

315.6

182

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

307.7

358

JN4AD

NOMESCO Finland

Body CT examination

15.4

307.7

789

717

LCD00

NOMESCO Finland

Hysterectomy

10.6

307.7

696

871

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

38.0

307.7

881

346

H02AB02

ATC

dexamethasone; systemic

193.8

307.7

1348

144

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

307.7

554

C56

ICD-10 Finland

Malignant neoplasm of ovary

11336.5

307.7

804

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

20.3

307.7

593

374

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2684.1

307.7

583

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

55.2

307.7

303

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

16.0

307.7

367

264

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

307.7

802

WW500

NOMESCO Finland

Blood transfusion

24.2

307.7

350

166

B01AB10

ATC

tinzaparin; parenteral

13.2

307.7

1061

1294

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

130.8

307.7

216

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

352

JAL00

NOMESCO Finland

Biopsy of peritoneum

165.6

307.7

345

128

Kela drug reimbursment

Cancers of female genital organs

16384.0

307.7

1413

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

307.7

1224

N02AA05

ATC

oxycodone; systemic

5.3

307.7

935

2483

JN4BD

NOMESCO Finland

Extensive body CT

20.8

307.7

740

488

WX302

NOMESCO Finland

Thoracal epidural anesthesy

42.0

307.7

746

247

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

20.4

307.7

778

533

JAL30

NOMESCO Finland

Omentectomy

256.4

307.7

893

JEA00

NOMESCO Finland

Appendectomy

18.1

307.7

797

619

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

5.8

307.7

810

1893

Z51.5

ICD-10 Finland

Palliative care

20.0

307.7

727

495

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

25.6

307.7

619

314

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

307.7

333

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1839.7

307.7

574

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

838.5

307.7

362

A03FA01

ATC

metoclopramide; systemic, rectal

17.6

307.7

1684

2473

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

8154.0

307.7

634

A04AA55

ATC

palonosetron, combinations; systemic

+∞

307.7

443

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

12.9

307.7

745

785

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

4452.4

307.7

690

L03AA13

ATC

pegfilgrastim; parenteral

7898.9

307.7

619

R18

ICD-10 Finland

Ascites

60.5

307.7

464

A04AA02

ATC

granisetron; systemic, transdermal

485.6

307.7

377

A04AA01

ATC

ondansetron; systemic, rectal

38.1

307.7

1108

498

L02BG04

ATC

letrozole; oral

67.1

307.7

478

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

26.0

300.1

211

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

295.6

278

L03AA02

ATC

filgrastim; parenteral

3001.7

295.4

280

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

112.1

289.2

148

JAH00

NOMESCO Finland

Laparotomy

14.1

282.3

268

210

TPX10

NOMESCO Finland

Implantation of vascular injection port

16.5

281.0

243

161

ZX120

NOMESCO Finland

Intravenous

7.0

280.7

479

809

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

11.4

277.6

304

298

TPH07

NOMESCO Finland

Cathetrisation of artery

5.9

276.0

586

1225

B01AB05

ATC

enoxaparin; parenteral

4.0

263.9

1374

5713

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

4.0

261.7

1459

6344

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

259.9

245

JAH01

NOMESCO Finland

Laparoscopy

8.0

258.2

380

544

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2527.8

253.2

241

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

251.2

237

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

250.1

236

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

10.8

246.1

278

284

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

12.3

242.5

250

223

130

Kela drug reimbursment

Malignant tumour

+∞

235.0

222

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

235.0

222

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

232.9

220

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

22.0

231.1

173

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

230.7

218

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

88.3

224.2

118

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2208.8

224.1

214

JAL31

NOMESCO Finland

Laparoscopic omentectomy

119.2

224.0

114

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

214.6

203

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

206.0

195

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

205.0

194

115

Kela drug reimbursment

Breast cancer

+∞

205.0

194

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

15.9

198.0

173

116

D70.82

ICD-10 Finland

Drug-induced neutropenia

55.2

195.6

111

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

1017.4

195.4

189

X77

ICPC

Malignant neopl genital female other

+∞

195.3

185

WF049

NOMESCO Finland

Radiotherapy of metastasis

994.1

191.2

185

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

+∞

187.8

178

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

186.8

177

WZC00

NOMESCO Finland

Treatment plan or consultation

3.2

185.2

1243

5745

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

17.5

183.2

152

L02BA01

ATC

tamoxifen; oral

626.9

179.8

176

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

10.6

175.8

198

200

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

35.5

173.0

109

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

12.8

172.8

171

142

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

168.6

160

PJA12

NOMESCO Finland

Sentinel node biopsy

355.6

168.2

168

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

11.4

168.0

180

169

JMA10

NOMESCO Finland

Transabdominal total splenectomy

91.1

167.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

167.5

159

Z31.5

ICD-10 Finland

Genetic counselling

6.8

166.6

278

451

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

34.2

164.8

105

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

53.6

162.9

3009

Kela drug reimbursment

Niraparib

+∞

162.2

154

JN3AD

NOMESCO Finland

Abdominal CT examination

3.8

159.9

582

1814

1510

Kela drug reimbursment

Niraparib

+∞

159.0

151

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

19.8

157.8

123

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.3

155.3

459

1230

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

151.6

144

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

58.6

151.5

JFB46

NOMESCO Finland

Resection of sigmoid colon

17.1

150.9

126

HA1AA

NOMESCO Finland

X-ray mammography

5.2

148.2

330

702

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

147.3

140

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

19.6

144.6

113

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.1

144.6

267

478

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1470.0

143.1

138

L01XK02

ATC

niraparib; oral

+∞

142.0

135

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

369.3

141.3

141

XX3DW

NOMESCO Finland

Time consuming IT work

5.5

141.0

297

601

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

11.3

136.7

146

136

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

136.7

130

HAB40

NOMESCO Finland

Wedge excision of mammary gland

15.8

135.6

118

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

134.6

128

WX402

NOMESCO Finland

General anaesthesia

3.1

134.0

751

3030

JFF10

NOMESCO Finland

Loop enterostomy

73.0

131.2

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

129.3

123

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

129.3

123

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

128.2

122

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

13.1

128.0

124

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

3.3

126.9

604

2208

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

125.0

119

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

125.0

119

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.0

124.7

700

2813

JFB00

NOMESCO Finland

Partial resection of small intestine

12.8

123.0

121

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

122.9

117

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

122.9

117

A06AH03

ATC

naloxegol; oral

24.3

121.9

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

121.8

116

ZXE20

NOMESCO Finland

More than three and less than five hours

3.5

118.4

474

1551

D39.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ovary

17.8

117.4

A04AA03

ATC

tropisetron; systemic

249.3

116.9

119

J94.8

ICD-10 Finland

Other specified pleural conditions

14.1

115.6

107

B03XA02

ATC

darbepoetin alfa; parenteral

12.1

114.1

116

100

ZXC40

NOMESCO Finland

Use of ultrasound

23.5

113.4

8460/3-C56.9

ICD-O-3

Low grade serous carcinoma of ovary

+∞

112.3

107

A79

ICPC

Malignancy NOS

291.1

109.9

111

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.4

109.6

228

454

WF002

NOMESCO Finland

Radical radiotherapy

26.1

109.4

WZC15, ,

NOMESCO Finland

56.8

107.9

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

22.9

106.9

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

146.2

106.0

112

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

106.0

101

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

3.1

104.0

509

1873

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

100.7

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

210.1

98.2

101

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

97.5

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

52.0

97.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

973.7

96.6

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

8.9

94.6

120

141

TJA10

NOMESCO Finland

Laparocentesis

147.0

93.7

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

46.8

93.5

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.0

93.4

170

298

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

143.9

91.7

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

13.2

91.6

JN4CD

NOMESCO Finland

Very extensive body CT

9.4

91.5

111

123

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

14.5

91.5

1511

Kela drug reimbursment

Olaparib

+∞

91.2

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

25.8

90.4

389

Kela drug reimbursment

Olaparib

+∞

90.1

K56.7

ICD-10 Finland

Ileus, unspecified

9.5

89.1

107

117

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

89.1

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

88.0

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

447.4

87.7

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

33.6

87.6

L01BC06

ATC

capecitabine; oral

+∞

87.0

A04AD12

ATC

aprepitant; systemic

436.7

85.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

85.6

447

1694

JFB30

NOMESCO Finland

Right hemicolectomy

18.3

84.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.4

84.2

171

332

HAC20

NOMESCO Finland

Total mastectomy

131.6

83.5

L01XK01

ATC

olaparib; oral

+∞

81.7

8480/3-C56.9

ICD-O-3

Mucinous adenocarcinoma of ovary

+∞

80.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

79.6

1XC07, ,

NOMESCO Finland

+∞

79.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

8.5

77.7

102

125

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

10.4

76.1

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

34.9

75.8

WZC30

NOMESCO Finland

Teaching

2.7

74.4

454

1860

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

74.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

73.6

482

2046

WF004

NOMESCO Finland

Palliative radiotherapy

728.2

72.5

C50.99

ICD-10 Finland

Breast, unspecified

367.3

72.0

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

71.6

1361

8986

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

3.9

71.1

224

616

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

70.1

C574, 8461, 3

ICD-O-3

+∞

69.1

JFF23

NOMESCO Finland

Transversostomy

19.3

67.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

67.0

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

229.1

65.5

JAW96

NOMESCO Finland

Other operation on abdominal wall, peritoneum, mesentery or omentum

28.0

64.9

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

3.3

64.5

264

861

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

139.6

64.2

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

643.7

64.1

R50.9

ICD-10 Finland

Fever, unspecified

2.6

63.4

425

1815

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

6.1

63.0

111

188

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

62.8

JFB20

NOMESCO Finland

Ileocaecal resection

19.2

62.3

L02AB02

ATC

medroxyprogesterone; systemic

13.4

62.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.6

61.9

214

626

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

61.7

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

13.3

58.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

58.9

318

1214

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

58.8

175

461

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

18.4

58.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

58.6

JFA70

NOMESCO Finland

Suture of small intestine

24.5

57.6

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.3

56.2

228

738

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

4.5

56.0

140

323

8442/1-C56.9

ICD-O-3

Serous borderline tumor, NOS, of ovary

13.2

55.5

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

55.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

55.4

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

8.6

54.7

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

13.7

54.6

WF003

NOMESCO Finland

Adjuvant radiotherapy

145.6

54.0

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

53.3

C567, ,

ICD-10 Finland

+∞

52.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.9

51.7

268

998

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

51.2

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.8

50.4

116

250

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

49.1

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

10.2

48.8

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

48.3

644

3629

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

48.1

N02AX02

ATC

tramadol; systemic, rectal

1.8

47.8

1200

8310

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

47.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

47.0

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

47.0

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

465.9

46.4

TJF80

NOMESCO Finland

Ostomy education

12.3

46.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

46.0

406

1946

KBV10

NOMESCO Finland

Removal of stent from ureter

11.4

45.8

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

17.9

45.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.4

45.5

170

KCH00

NOMESCO Finland

Suture of bladder

15.8

45.2

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.9

45.2

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

44.9

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

43.9

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

43.9

8102

FHL

Second look"" surgery for a malignant tumor

434.8

43.3

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

434.8

43.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

41.8

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

41.8

Z93.3

ICD-10 Finland

Colostomy status

15.0

41.7

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

7.0

41.2

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

40.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.9

40.4

185

LEB00

NOMESCO Finland

Biopsy of vagina

4.3

40.1

104

247

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

40.0

936

6256

C50

ICD-10 Finland

Malignant neoplasm of breast

142.3

39.8

ZX090

NOMESCO Finland

Other technic of radiotherapy

109.3

39.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

39.8

1071

7448

8980/3-C56.9

ICD-O-3

Carcinosarcoma, NOS, of ovary

+∞

39.7

L01CB01

ATC

etoposide; systemic

+∞

39.7

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

12.8

39.2

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

65.3

39.2

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

38.6

8000/3-C56.9

ICD-O-3

Neoplasm, malignant of ovary

+∞

38.6

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

38.6

TGA30

NOMESCO Finland

Thoracocentesis

14.2

38.2

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.3

37.8

147

462

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

36.7

158

528

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

36.5

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

36.5

XX2RW, ,

NOMESCO Finland

8.0

36.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.8

36.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.6

35.8

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

+∞

35.5

L01XX54

ATC

[U] niraparib

+∞

35.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

34.5

247

1074

1XA02, ,

NOMESCO Finland

+∞

34.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

33.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

33.2

257

1157

JFB43

NOMESCO Finland

Left hemicolectomy

12.9

33.2

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.9

33.2

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

64.2

33.1

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

331.2

33.0

R11

ICD-10 Finland

Nausea and vomiting

2.2

32.9

305

1481

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

45.1

32.8

ZX121

NOMESCO Finland

Central venous catheter

118.2

32.7

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

7.0

32.7

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

4.2

32.6

220

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

+∞

32.4

JFA80

NOMESCO Finland

Suture of colon

40.6

32.2

A98

ICPC

Health maint/preventive medicine

0.5

32.0

2273

24333

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

320.9

31.9

R4190

NOMESCO Finland

Nutritional therapy

3.6

31.5

105

299

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

31.3

L02BG03

ATC

anastrozole; oral

+∞

31.3

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

31.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

31.3

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

8.8

31.1

SPAT1153

SPAT

Removal of sutures

1.7

31.0

829

5659

K56.0

ICD-10 Finland

Paralytic ileus

7.6

31.0

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

161.9

30.7

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.8

30.5

258

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

30.3

L02BA03

ATC

fulvestrant; parenteral

+∞

30.3

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

30.3

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

6.6

29.8

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

45.6

29.7

GD1AD

NOMESCO Finland

Thorax CT examination

2.8

29.6

159

600

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

10.8

29.6

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.2

29.5

188

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

29.3

139

491

JN6AD

NOMESCO Finland

CT of torso and neck

8.7

29.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

29.2

8140/3-C56.9

ICD-O-3

Adenocarcinoma, NOS, of ovary

+∞

29.2

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

11.7

29.2

A02BC02

ATC

pantoprazole; systemic

1.7

29.0

1859

15639

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

6.0

28.7

ZX080

NOMESCO Finland

Image guided radiotherapy

151.7

28.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

28.2

C48.00

ICD-10 Finland

Malignant tumor of the retroperitoneal space without histology

+∞

28.2

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.9

27.9

126

X76

ICPC

Malignant neoplasm breast female

101.2

27.7

ZXC96

NOMESCO Finland

Robot assisted procedure

6.7

27.7

N02AA01

ATC

morphine; systemic, rectal

5.8

27.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

27.4

287

1457

JBA20

NOMESCO Finland

Transabdominal partial excision of diaphragm

+∞

27.1

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

27.1

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.2

27.0

179

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

26.9

288

1474

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

273.8

26.8

TPX15

NOMESCO Finland

Removal of vascular injection port

28.1

26.7

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

4.0

26.4

191

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.4

26.1

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

26.1

L02BG06

ATC

exemestane; oral

+∞

26.1

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

26.1

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

26.1

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

26.1

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

26.1

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

26.1

ZX070

NOMESCO Finland

Intensity modified radiotherapy

73.4

25.8

C10AA07

ATC

rosuvastatin; oral

0.6

25.7

509

7665

8620/1-C56.9

ICD-O-3

Adult granulosa cell tumor of testis of ovary

136.4

25.6

KBV00

NOMESCO Finland

Insertion of stent into ureter

9.2

25.6

B01AB04

ATC

dalteparin; parenteral

2.6

25.6

153

610

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.5

25.5

144

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

6.9

25.5

RS220, ,

NOMESCO Finland

5.4

25.4

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

25.0

3AA13, ,

NOMESCO Finland

+∞

25.0

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

25.0

ZX112

NOMESCO Finland

Subcutaneous

6.3

24.9

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

252.5

24.7

X81

ICPC

Genital neopl female other/unspecif

27.8

24.5

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

9.4

24.4

S18

ICPC

Laceration/cut

1.5

24.3

1205

9376

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

24.0

110

381

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

24.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

24.0

9080/3-C56.9

ICD-O-3

Teratoma, malignant, NOS, of ovary

+∞

24.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

23.9

225

1095

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.8

23.9

372

2159

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

23.8

268

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

27.0

23.6

WPB10

NOMESCO Finland

Making a convalescent care decision

28.5

23.2

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

54.5

23.1

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

18.7

23.0

8461/3-C48.2

ICD-O-3

High grade serous carcinoma of peritoneum, NOS

+∞

22.9

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

22.9

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

232.0

22.6

Z51.0

ICD-10 Finland

Radiotherapy session

121.1

22.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

19.1

22.6

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

8.8

22.4

PJA10

NOMESCO Finland

Exploration of lymph nodes

8.8

22.4

JAL96

NOMESCO Finland

Other excision of lesion of peritoneum

32.6

22.4

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

27.6

22.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.3

22.2

255

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

21.9

267

1CD02, ,

NOMESCO Finland

+∞

21.9

L01XX46

ATC

[U] olaparib

+∞

21.9

R2110

NOMESCO Finland

Giving the first information

2.1

21.9

213

1050

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

21.8

425

2632

D69.5

ICD-10 Finland

Secondary thrombocytopenia

22.4

21.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

21.4

507

3305

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.9

21.4

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

23.3

21.3

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

34.1

21.1

LAF17

NOMESCO Finland

Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

+∞

20.9

8010/3-C56.9

ICD-O-3

Carcinoma, NOS, of ovary

+∞

20.9

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

6.7

20.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.8

20.8

173

KA1FN

NOMESCO Finland

Isotope renography

7.9

20.4

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

48.4

20.2

LCD30

NOMESCO Finland

Radical hysterectomy

58.0

19.9

C48.20

ICD-10 Finland

Malignant tumor in unspecified localization in the peritoneum without histology

+∞

19.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

19.8

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

19.8

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

19.8

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

19.8

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.3

19.7

117

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

29.2

19.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

105.9

19.6

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

201.5

19.6

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

19.5

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

21.8

19.5

WX600

NOMESCO Finland

Single shot through catheter

4.7

19.4

WX892

NOMESCO Finland

Monitored bed care

2.1

18.8

177

861

9060/3-C56.9

ICD-O-3

Dysgerminoma of ovary

+∞

18.8

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

18.8

8440/3-C56.9

ICD-O-3

Cystadenocarcinoma, NOS, of ovary

+∞

18.8

Z2446

NOMESCO Finland

Social worker

2.3

18.7

149

677

N02BE01

ATC

paracetamol; systemic, rectal

1.9

18.4

2357

21854

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

6.3

18.0

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

18.0

159

3094

JFF30

NOMESCO Finland

Other colostomy

33.1

18.0

JKA20

NOMESCO Finland

Cholecystectomy

3.1

17.9

242

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

17.9

1228

14621

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

26.9

17.8

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

17.7

423

6214

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

17.7

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

17.7

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

17.7

C10AA05

ATC

atorvastatin; oral

0.7

17.6

695

9175

K83.1

ICD-10 Finland

Obstruction of bile duct

5.3

17.5

M79.6

ICD-10 Finland

Pain in limb

0.7

17.4

805

10319

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.1

17.4

120

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.8

17.3

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.6

17.0

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

16.0

17.0

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

50.3

17.0

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.8

16.9

299

WPA13

NOMESCO Finland

Palliative consultation

13.3

16.9

JFF13

NOMESCO Finland

Terminal enterostomy

25.8

16.9

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

63.7

16.7

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

16.7

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

16.7

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

16.7

C76.3

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Pelvis

+∞

16.7

JAL23

NOMESCO Finland

Excision of local lesion of pelvic wall

+∞

16.7

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

16.7

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

16.7

ZZR00

NOMESCO Finland

Flap of skin

6.5

16.7

JBA00

NOMESCO Finland

Transabdominal repair of diaphragm for rupture

90.7

16.6

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.7

16.3

144

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

16.2

910

7088

JFB50

NOMESCO Finland

Other resection of colon

21.1

16.0

JN3DM

NOMESCO Finland

Abdominal very extensive MRI examination with 3 Tesla magnet

60.4

15.8

TQW20

NOMESCO Finland

Tatoe

33.6

15.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

33.6

15.7

HAC25

NOMESCO Finland

Radical mastectomy

+∞

15.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

15.6

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

15.6

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

15.6

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

15.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

15.6

JFC20

NOMESCO Finland

Other enterocolostomy

+∞

15.6

C48.19

ICD-10 Finland

Malignant tumor in specified location in peritoneum other or unspecified histlogy

+∞

15.6

GAE03

NOMESCO Finland

Suture of chest wall

+∞

15.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

15.6

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

15.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

15.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

17.3

15.6

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

85.6

15.6

Z51.88

ICD-10 Finland

Other specified medical care

3.0

15.6

230

SPAT1125

SPAT

Stoma care and guidance

3.5

15.6

149

LWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gynaecological surgery

22.2

15.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

160.9

15.5

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

160.9

15.5

L15

ICPC

Knee symptom/complaint

0.6

15.4

427

6100

TLE30

NOMESCO Finland

Tamponation of vagina

12.4

15.3

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

5.0

15.3

WPA44, ,

SPAT

17.8

15.1

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.4

15.0

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

10.9

15.0

R06AE07

ATC

cetirizine; oral

1.4

14.9

1188

9798

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

57.0

14.8

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.5

14.7

118

2384

1CD01, ,

NOMESCO Finland

+∞

14.6

D39.13

ICD-10 Finland

Uncertain growth nature of the ovarian tumor, sex chord derived

+∞

14.6

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

14.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

14.6

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

14.6

C10AX09

ATC

ezetimibe; oral

0.5

14.6

182

3189

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

80.6

14.6

JA3HT

NOMESCO Finland

Tissue sample of abdominal tissue change under UA control

150.8

14.5

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

150.8

14.5

M54.5

ICD-10 Finland

Low back pain

0.7

14.4

600

7929

Z3231

NOMESCO Finland

Registered nurse

1.5

14.4

592

4329

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

12.6

14.4

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

14.1

153

784

8205

FHL

Subradical ovarian malignancy removal (includes possible genital and omet removal)

42.7

14.1

C03CA01

ATC

furosemide; systemic

1.4

13.9

760

5854

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.4

13.9

141

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

53.6

13.8

JFB40

NOMESCO Finland

Resection of transverse colon

53.6

13.8

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

53.6

13.8

ZZR10

NOMESCO Finland

Flap of skin and muscle

20.1

13.8

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.7

13.8

D77

ICPC

Malignant digestive neopl other/NOS

75.5

13.6

GAE06

NOMESCO Finland

Excision of lesion of chest wall

75.5

13.6

WPA40

NOMESCO Finland

Individual-centered psychosocial intervention in palliative care

75.5

13.6

L13

ICPC

Hip symptom/complaint

0.6

13.6

335

4933

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

13.5

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

13.5

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

13.5

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

13.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

13.5

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

13.5

D64.2

ICD-10 Finland

Secondary sideroblastic anaemia due to drugs and toxins

+∞

13.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.8

13.5

110

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

140.7

13.5

A06AD11

ATC

lactulose; oral

1.6

13.4

369

2476

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

21.3

13.3

D39.18

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with other definite histology

40.3

13.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.7

13.1

B03XA01

ATC

erythropoietin; parenteral

6.2

12.9

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

19.1

12.9

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

22.6

12.9

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

50.3

12.8

L08

ICPC

Shoulder symptom/complaint

0.6

12.8

345

4990

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

14.1

12.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.5

12.7

5703

FHL

Removal of lymph nodes from the retroperitoneal space

70.2

12.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

70.2

12.6

WPA43, ,

SPAT

32.2

12.6

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.6

12.5

116

KA3EB

NOMESCO Finland

Antegrade pyelography

11.0

12.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

11.0

12.5

1DB01, ,

NOMESCO Finland

+∞

12.5

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

12.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

12.5

8441/2-C57.0

ICD-O-3

Serous intraepithelial carcinoma of fallopian tube

+∞

12.5

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

12.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

12.5

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

12.5

C569, ,

ICD-10 Finland

+∞

12.5

C78.5

ICD-10 Finland

Secondary malignant neoplasm of large intestine and rectum

+∞

12.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

12.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

12.5

M01AH05

ATC

etoricoxib; oral

0.7

12.5

1231

14255

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

130.6

12.4

EB4VA, ,

NOMESCO Finland

0.6

12.4

183

3068

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

12.4

1414

16036

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

12.3

125

626

ZX100

NOMESCO Finland

Oral

4.1

12.3

SDA03

NOMESCO Finland

Periodontal treatment

0.7

12.3

663

8433

M25.5

ICD-10 Finland

Pain in joint

0.7

12.3

569

7426

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

12.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

12.1

180

R03AC02

ATC

salbutamol; inhalant

0.7

12.1

1049

12406

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

4.1

12.0

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.6

12.0

110

N83.5

ICD-10 Finland

Torsion of ovary, ovarian pedicle and fallopian tube

4.9

11.9

J01DB01

ATC

cefalexin; oral

1.4

11.9

2028

18577

Z01.2

ICD-10 Finland

Dental examination

0.7

11.9

812

9961

N80.1

ICD-10 Finland

Endometriosis of ovary

2.5

11.8

309

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.8

LAE10

NOMESCO Finland

Unilateral oophorectomy

5.9

11.8

D39.12

ICD-10 Finland

Granulosa cell tumor of uncertain nature in the ovary

65.2

11.6

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

11.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

11.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

11.5

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

11.5

9071/3-C56.9

ICD-O-3

Yolk sac tumor, NOS, of ovary

+∞

11.5

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

11.5

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

11.5

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

11.5

C54.0

ICD-10 Finland

Malignant neoplasm: Isthmus uteri

+∞

11.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

11.5

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

120.5

11.4

A21

ICPC

Risk factor for malignancy

120.5

11.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

120.5

11.4

L03

ICPC

Low back symptom/complaint

0.7

11.4

501

6621

WX320

NOMESCO Finland

Spinalanesthesy

0.7

11.3

351

4951

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.2

11.3

WX704

NOMESCO Finland

Intubation

1.8

11.2

181

1058

L17

ICPC

Foot/toe symptom/complaint

0.7

11.1

538

6999

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

25.1

11.1

LBE00

NOMESCO Finland

Salpingectomy

4.2

11.1

N05CF01

ATC

zopiclone; oral

1.4

11.0

826

6653

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

11.0

402

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

11.0

246

3723

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

10.9

184

1088

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

10.8

159

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

12.0

10.8

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

15.5

10.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.7

10.8

538

6970

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

28.1

10.7

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

17.9

10.7

K02.1

ICD-10 Finland

Caries of dentine

0.8

10.7

1021

12001

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

10.7

619

4781

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.6

10.7

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.9

10.6

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

3.6

10.6

D27.93

ICD-10 Finland

Benign ovarian tumor, sex chord stroma derived

60.2

10.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

10.6

112

570

N05AD01

ATC

haloperidol; systemic

2.4

10.6

301

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.7

10.5

380

5214

LAE20

NOMESCO Finland

Bilateral oophorectomy

4.8

10.5

C57.7

ICD-10 Finland

Malignant neoplasm: Other specified female genital organs

+∞

10.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

10.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

1501

Kela drug reimbursment

Palbociclib

+∞

10.4

L01EF01

ATC

palbociclib; oral

+∞

10.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

10.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

10.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

10.4

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

10.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

10.4

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

10.4

9110/3-C56.9

ICD-O-3

Mesonephroma, malignant of ovary

+∞

10.4

8310

FHL

Radical hysterectomy (includes lymph node removal)

+∞

10.4

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

10.4

394

Kela drug reimbursment

Palbociclib

+∞

10.4

D27.92

ICD-10 Finland

Benign granulosa cell tumor in ovary (ovary)

8.8

10.3

Z93

ICD-10 Finland

Artificial opening status

23.4

10.2

WW200, ,

SPAT

0.7

10.1

518

6698

JAD10

NOMESCO Finland

Repair of incisional hernia

4.2

10.1

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.1

627

4895

Z93.2

ICD-10 Finland

Ileostomy status

8.5

10.0

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

10.0

407

5472

D48.41

ICD-10 Finland

Ovarian tumor of uncertain or unknown nature in the peritoneum

40.2

10.0

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

40.2

10.0

R01AD58

ATC

fluticasone, combinations; nasal

0.7

9.9

335

4663

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.4

9.9

100

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

16.8

9.9

R4110, ,

SPAT

0.6

9.8

199

3088

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.7

1052

8892

R96

ICPC

Asthma

0.5

9.7

123

2156

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

9.7

181

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

9.7

254

3719

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.9

9.6

159

JAH96

NOMESCO Finland

Other opening of peritoneal cavity

55.2

9.6

JFC00

NOMESCO Finland

Entero-enterostomy

55.2

9.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.6

149

861

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

9.1

9.5

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

10.1

9.5

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

10.1

9.5

JFC10

NOMESCO Finland

Ileotransversostomy

100.4

9.4

I89.8

ICD-10 Finland

Other specified noninfective disorders of lymphatic vessels and lymph nodes

100.4

9.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

100.4

9.4

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

30.1

9.4

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

9.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

9.4

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

9.4

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

9.4

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

+∞

9.4

C48.09

ICD-10 Finland

Malignant tumor of the retroperitoneal space other or unspecified tumor

+∞

9.4

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

9.4

C579, 8461, 3

ICD-O-3

+∞

9.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

9.4

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

9.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

9.4

C48.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum

+∞

9.4

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

9.4

X75

ICPC

Malignant neoplasm cervix

+∞

9.4

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

+∞

9.4

D630, C5671,

ICD-10 Finland

+∞

9.4

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

9.4

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

9.4

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

9.4

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

3.5

9.3

XX1VW

NOMESCO Finland

Written report from radiologist

4.0

9.3

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

9.5

9.3

G02BA03

ATC

plastic IUD with progestogen

0.5

9.2

1824

LCC10

NOMESCO Finland

Supravaginal hysterectomy

3.5

9.2

R74

ICPC

Upper respiratory infection acute

0.7

9.1

478

6178

R01AD12

ATC

fluticasone furoate; nasal

0.7

9.1

470

6088

A26

ICPC

Fear of cancer, NOS

5.0

9.1

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

36.8

9.0

XX1AD

NOMESCO Finland

Other CT-examination

36.8

9.0

E89.4

ICD-10 Finland

Postprocedural ovarian failure

36.8

9.0

D99

ICPC

Disease digestive system other

3.5

8.9

SPAT1076

SPAT

Cannulation of central vein

24.1

8.9

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

8.9

319

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.8

8.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.6

8.8

163

2588

R03DC03

ATC

montelukast; oral

0.7

8.8

232

3401

R06AX27

ATC

desloratadine; oral

0.7

8.8

443

5765

UKC02

NOMESCO Finland

Cystoscopy

1.5

8.8

255

1726

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

8.8

400

5292

WGA11

NOMESCO Finland

Planning of pain management

7.2

8.7

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.7

8.7

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

8.7

426

5571

D27.98

ICD-10 Finland

Benign tumor of the ovary (ovary), other specified histology

3.9

8.7

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

14.1

8.7

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

14.1

8.7

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

50.2

8.7

D82

ICPC

Teeth/gum disease

0.7

8.6

590

7336

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

8.6

385

5114

OAB42, ,

SPAT

0.6

8.6

146

2370

D07AC13

ATC

mometasone; topical

1.3

8.6

684

5522

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

8.6

211

JGA60

NOMESCO Finland

Suture of rectum

16.3

8.5

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

16.3

8.5

SPAT1269

SPAT

Other puncture and/or drainage

6.9

8.5

D39.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other female genital organs

9.0

8.5

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.0

8.5

A28

ICPC

Limited function/disability NOS

1.4

8.5

474

3625

D19

ICPC

Teeth/gum symptom/complaint

0.7

8.5

478

6119

H01CB02

ATC

octreotide; parenteral

27.6

8.5

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

27.6

8.5

8472/1-C56.9

ICD-O-3

Mucinous cystic tumor of borderline malignancy of ovary

7.4

8.4

P20

ICPC

Memory disturbance

0.6

8.4

211

3128

YX9AW, ,

NOMESCO Finland

90.4

8.4

EB1VA, ,

NOMESCO Finland

0.7

8.4

229

3335

G03FA01

ATC

norethisterone and estrogen; systemic

0.7

8.3

306

4209

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

8.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

8.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

8.3

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

8.3

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

8.3

L01BC59

ATC

trifluridine, combinations; systemic

+∞

8.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

8.3

C90.0

ICD-10 Finland

Multiple myeloma

+∞

8.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

8.3

L01CA04

ATC

vinorelbine; systemic

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

192

Kela drug reimbursment

Fulvestrant

+∞

8.3

C48.80

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum without histology

+∞

8.3

C48.10

ICD-10 Finland

Malignant tumor in specified location in the peritoneum without histology

+∞

8.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

8.3

J91, C5671,

ICD-10 Finland

+∞

8.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

8.3

C54.23

ICD-10 Finland

Carcinosarcoma

+∞

8.3

Z2221

NOMESCO Finland

Medical doctor

1.3

8.3

591

4689

UJF32

NOMESCO Finland

Coloscopy

1.3

8.3

618

4937

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

8.5

8.3

L02AE02

ATC

leuprorelin; implant, parenteral

3.6

8.3

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

8.2

2229

21084

R42

ICD-10 Finland

Dizziness and giddiness

0.7

8.2

403

5275

SFA20

NOMESCO Finland

Two-surface restoration

0.8

8.2

1082

12375

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.3

8.2

688

D75

ICPC

Malignant neoplasm colon/rectum

14.5

8.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.8

8.2

641

7829

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

8.1

207

3059

SPAT1290

SPAT

Preparation of deceased person

33.4

8.1

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

11.7

8.1

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.0

8.0

407

KBH20

NOMESCO Finland

Replantation of ureter

10.1

8.0

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

8.0

480

6095

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

8.0

322

2327

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

8.0

408

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

7.9

512

6430

SFA10

NOMESCO Finland

One-surface restoration

0.8

7.9

1016

11676

J94.9

ICD-10 Finland

Pleural condition, unspecified

7.8

7.9

G47.3

ICD-10 Finland

Sleep apnoea

0.7

7.8

242

3440

N17

ICPC

Vertigo/dizziness

0.6

7.8

191

2849

N06DX01

ATC

memantine; oral

0.5

7.8

1458

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.5

7.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

7.8

995

11452

Y60.8

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during other surgical and medical care

10.8

7.8

UKB02

NOMESCO Finland

Retrograde ureteroscopy

4.2

7.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

45.1

7.7

KC1GB

NOMESCO Finland

Cystography with X-ray

15.1

7.7

H13

ICPC

Plugged feeling ear

0.7

7.7

263

3667

G03AC03

ATC

levonorgestrel; oral, implant

0.6

7.6

168

2563

M01AB05

ATC

diclofenac; systemic, rectal

0.8

7.6

1322

14705

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.9

7.6

118

H02

ICPC

Hearing complaint

0.7

7.6

205

2993

XLD10

NOMESCO Finland

Gynaecological examination

3.6

7.6

HAE99

NOMESCO Finland

Other reconstruction of breast

11.9

7.6

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

25.1

7.6

C10AA01

ATC

simvastatin; oral

0.8

7.6

738

8786

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

2.8

7.5

135

TQB05

NOMESCO Finland

Puncture of skin of trunk

8.9

7.5

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

7.5

1016

11637

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

7.5

788

9297

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.6

7.5

153

D39

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of female genital organs

80.3

7.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

80.3

7.4

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

80.3

7.4

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

80.3

7.4

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

7.4

214

N02AA03

ATC

hydromorphone; systemic, rectal

13.4

7.4

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

7.4

114

659

K65.0

ICD-10 Finland

Acute peritonitis

3.4

7.4

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

7.4

160

J01MA12

ATC

levofloxacin; systemic

1.4

7.3

351

2613

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.8

7.3

113

653

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

8461/3-C48.1

ICD-O-3

High grade serous carcinoma of specified parts of peritoneum

+∞

7.3

JN4DD

NOMESCO Finland

Scout CT scan of torso

+∞

7.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

7.3

KBH06

NOMESCO Finland

Ureteroureterostomy

+∞

7.3

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

+∞

7.3

C48.29

ICD-10 Finland

Malignant tumor in unspecified localization in peritoneum other or unspecified histology

+∞

7.3

8441/3-C57.0

ICD-O-3

Serous carcinoma, NOS, of fallopian tube

+∞

7.3

8380/3-C57.0

ICD-O-3

Endometrioid adenocarcinoma, NOS, of fallopian tube

+∞

7.3

L01AX03

ATC

temozolomide; systemic

+∞

7.3

WE198

NOMESCO Finland

Palliative cystotatic therapy

+∞

7.3

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

7.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

7.3

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

+∞

7.3

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

7.3

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.3

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

7.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

7.3

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

7.3

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

7.3

8020/3-C56.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of ovary

+∞

7.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

7.3

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

7.3

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

7.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

7.3

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

10.9

7.3

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.3

7.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

15.8

7.2

R4110

NOMESCO Finland

Physiotherapy

1.3

7.2

588

4746

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

7.3

7.2

R84

ICPC

Malignant neoplasm bronchus/lung

30.1

7.1

2362A

ICD-9 Finland

Neoplasm of uncertain behaviour of genito-urinary organs, Ovary

30.1

7.1

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.8

7.1

123

R05

ICPC

Cough

0.7

7.0

423

5385

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.8

7.0

612

7408

G44.2

ICD-10 Finland

Tension-type headache

0.7

7.0

189

2762

L90

ICPC

Osteoarthrosis of knee

0.6

6.9

1555

SPAT1088

SPAT

Blood transfusion

7.5

6.9

ZX050

NOMESCO Finland

Stereotactic radiotherapy

13.8

6.9

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

6.9

362

4701

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

8.3

6.8

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

4.1

6.8

8380/2-C54.1

ICD-O-3

Endometrioid intraepithelial neoplasia of endometrium

6.7

6.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.7

6.8

279

3772

LAB11

NOMESCO Finland

Laparoscopic biopsy of ovary

40.2

6.8

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

40.2

6.8

Z43.3

ICD-10 Finland

Attention to colostomy

40.2

6.8

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

40.2

6.8

LAC96

NOMESCO Finland

Other excision or destruction of lesion of ovary

40.2

6.8

F29

ICPC

Eye symptom/complaint other

0.6

6.7

128

2021

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

6.7

513

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

16.7

6.7

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

2.8

6.7

115

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

6.7

1317

14559

LCF00

NOMESCO Finland

Excision of lesion of parametrium

22.6

6.7

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.7

6.6

133

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.7

6.6

199

2849

L12

ICPC

Hand/finger symptom/complaint

0.7

6.6

254

3476

N06DA02

ATC

donepezil; oral

0.5

6.6

1243

N01

ICPC

Headache

0.6

6.6

122

1940

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

6.6

654

5406

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

5.5

6.6

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.5

6.6

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.5

6.6

157

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

3.6

6.6

N05AX08

ATC

risperidone; systemic

0.6

6.6

1432

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

1.9

6.6

423

N81.6

ICD-10 Finland

Rectocele

0.6

6.6

124

1961

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

12.3

6.6

306

Kela drug reimbursment

Erythropoietin and darbepoetin

12.3

6.6

R03BA02

ATC

budesonide; inhalant

0.7

6.5

264

3582

WPA11

NOMESCO Finland

Developing a plan for palliative care

8.7

6.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

6.5

350

4538

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

6.5

951

8225

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

3.8

6.5

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

10.0

6.5

J45.9

ICD-10 Finland

Asthma, unspecified

0.7

6.5

305

4038

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

6.9

6.5

M79.1

ICD-10 Finland

Myalgia

0.7

6.5

206

2918

H25.1

ICD-10 Finland

Senile nuclear cataract

0.8

6.4

540

6582

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

0.4

6.4

762

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

70.0

6.4

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

70.0

6.4

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

70.0

6.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

70.0

6.4

Z3232

NOMESCO Finland

Midwife

1.7

6.4

117

710

KMAK, ,

NOMESCO Finland

0.8

6.4

906

10385

OAB44, ,

SPAT

0.6

6.3

104

1702

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.7

6.3

215

3008

SFA30

NOMESCO Finland

Three-surface restoration

0.8

6.3

743

8699

S77

ICPC

Malignant neoplasm of skin

11.0

6.3

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

11.0

6.3

JG1BG

NOMESCO Finland

MRI of rectum

18.1

6.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

6.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

6.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

6.3

V03AF03

ATC

calcium folinate; systemic

+∞

6.3

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

6.3

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

6.3

Z93.8

ICD-10 Finland

Other artificial opening status

+∞

6.3

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

6.3

8240/3-C56.9

ICD-O-3

Neuroendocrine tumor, NOS, of ovary

+∞

6.3

8140/3-C54.1

ICD-O-3

Adenocarcinoma, NOS, of endometrium

+∞

6.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

6.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

6.3

C57.4

ICD-10 Finland

Malignant neoplasm: Uterine adnexa, unspecified

+∞

6.3

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

6.3

JN3HE

NOMESCO Finland

Simple abdominal follow-up ultrasound

+∞

6.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.3

KBD00

NOMESCO Finland

Partial excision of ureter

+∞

6.3

C80.98

ICD-10 Finland

Malignant tumor without specified localization other specified histology

+∞

6.3

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

6.3

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

6.3

WB313

NOMESCO Finland

Adjuvant multiple therapy of malignancy with biomodifiers

+∞

6.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

6.3

GEB40

NOMESCO Finland

Mediastinotomy and extended excision of lesion

+∞

6.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

6.3

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

6.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.3

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

6.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

6.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

6.3

R01AD08

ATC

fluticasone; nasal

0.8

6.2

452

5619

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.6

6.2

135

2068

KCD10

NOMESCO Finland

Partial cystectomy

26.7

6.2

JDE00

NOMESCO Finland

Gastrojejunostomy

26.7

6.2

JFA83

NOMESCO Finland

Excision of lesion of colon

26.7

6.2

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

26.7

6.2

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

26.7

6.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.7

6.2

235

3223

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

6.2

276

3684

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

6.1

LEE00

NOMESCO Finland

Suture of vagina

7.7

6.1

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.5

6.1

1236

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

6.1

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.8

6.1

451

5589

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.6

6.1

123

1911

JFF26

NOMESCO Finland

Sigmoidostomy

10.0

6.0

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

10.0

6.0

R05FB02

ATC

cough suppressants and expectorants; systemic

0.8

6.0

713

8355

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.7

6.0

170

2463

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1854

1318

46.80

307.65

16.0

1.5

162.99

26.30

u/ml

18.93

1828

1255

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

274

87.41

307.65

6.5

1.3

116.81

66.14

ng/l

—

135

(4035726) Immunohistochemistry procedure

821

637

18.39

307.65

1.4

1.2

—

(4281824) Cell count and differential, peritoneal fluid

760

163

65.53

307.65

1.3

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1057

587

29.70

307.65

1.8

1.4

467.56

73.50

pmol/l

26.61

1019

569

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1200

1233

17.25

307.65

2.5

1.5

7.25

2.61

ug/l

4.35

871

931

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

385

482

9.21

293.71

2.6

1.9

101.40

17.86

u/ml

1.70

326

383

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

164

38.84

266.08

2.3

1.0

60.76

16.23

u/ml

5.88

157

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

224

146

16.70

260.99

5.1

1.2

21.47

2.92

ug/l

2.31

121

122

(3012095) Magnesium [Moles/volume] in Serum or Plasma

978

3390

4.03

240.89

6.7

2.3

0.78

0.82

mmol/l

19.56

950

3116

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

179

108

17.73

216.41

1.1

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1407

6618

3.46

210.34

3.0

2.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1860

10418

3.78

209.13

6.6

3.7

32.78

36.09

g/l

85.32

1800

9580

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1786

9870

3.60

202.37

3.5

2.4

—

estimate

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

301

471

7.10

187.13

1.7

2.3

3.75

3.54

g/l

1.34

293

441

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1131

5025

3.22

178.91

3.0

2.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

119

29.65

178.61

1.3

3.0

7752.26

839.43

e6/l

0.73

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

231

282

8.89

177.87

2.2

312.65

22.50

u/ml

1.32

208

255

(40768806) Pleura Pathology biopsy report

143

16.95

169.85

1.4

1.6

—

(3023368) Bacteria identified in Blood by Culture

1148

5310

3.08

166.70

4.4

3.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1871

11397

3.30

164.89

11.8

3.7

9.12

10.45

umol/l

5.21

1824

10623

(3003396) Base excess in Arterial blood by calculation

662

2238

3.63

161.18

6.5

6.9

0.61

1.41

mmol/l

6.39

572

1849

(3027801) Oxygen [Partial pressure] in Arterial blood

661

2258

3.59

158.08

6.5

6.9

15.81

11.83

kpa

40.71

644

2158

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

661

2261

3.58

157.72

6.6

6.9

5.09

5.10

kpa

0.04

644

2167

(3019977) pH of Arterial blood

660

2268

3.56

156.22

6.6

7.0

7.41

7.42

2.77

373

1284

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

104

28.47

154.13

1.3

2.3

10152.65

89686.72

e6/l

0.69

(3044007) Cell count panel - Peritoneal fluid

101

27.62

148.16

1.4

2.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

563

1844

3.62

142.32

6.7

7.7

112.94

119.46

g/l

15.31

550

1791

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

538

1747

3.62

137.43

1.9

2.1

0.19

0.21

g/l

2.88

507

1598

(3013650) Neutrophils [#/volume] in Blood by Automated count

1904

12385

3.02

136.09

23.9

6.6

3.75

4.10

e9/l

9.09

1658

10495

(40768804) Tissue Pathology biopsy report

1417

8453

2.49

111.17

2.6

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

1024

5360

2.50

105.55

5.2

3.4

94.52

93.49

0.78

1006

5223

(3003434) Protein [Mass/volume] in Pleural fluid

133

162

8.60

101.95

1.2

1.4

39.22

27.28

g/l

14.42

126

138

(3032080) INR in Blood by Coagulation assay

1595

10297

2.43

101.29

10.7

14.9

1.15

1.24

inr

11.05

1304

8473

(3008152) Bicarbonate [Moles/volume] in Arterial blood

394

1270

3.48

99.81

7.9

6.6

24.45

24.94

mmol/l

1.77

381

1212

(3023199) Leukocytes [#/volume] in Pleural fluid

126

150

8.78

98.34

1.3

1.5

1468.61

2188.34

e6/l

0.36

108

(3036489) Thrombin time

289

761

4.15

98.24

1.7

1.8

20.65

20.61

0.04

281

653

(3019060) Gas panel - Arterial blood

374

1181

3.53

97.72

4.9

4.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

258

636

4.39

95.64

5.1

3.9

1.31

1.35

mmol/l

0.20

258

618

(3016502) Oxygen saturation in Arterial blood

511

1978

2.97

94.85

6.7

7.3

97.14

95.22

9.40

496

1902

(3002256) Pathology report gross observation

502

1937

2.97

93.62

1.3

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

113

125

9.41

93.33

1.2

1.5

18364.65

81340.82

e6/l

0.54

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

481

1829

3.00

91.97

5.0

2.3

258.87

232.20

u/l

3.26

464

1694

(3018677) aPTT in Platelet poor plasma by Coagulation assay

673

3178

2.51

83.37

2.4

2.0

28.65

29.29

2.40

662

3080

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

356

1224

3.21

80.40

7.7

8.6

1.44

1.34

1.28

356

1217

(3014007) Fractional oxyhemoglobin in Arterial blood

351

1219

3.17

77.83

7.9

8.7

95.08

93.48

4.45

351

1214

(3042936) Bacteria identified in Isolate by Culture

609

2851

2.48

76.04

1.9

—

(3012441) Differential panel - Pleural fluid

118

8.59

75.68

1.3

1.5

—

(3003694) ABO and Rh group [Type] in Blood

963

5508

2.19

74.91

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1871

22260

0.43

74.63

5.7

6.7

39.29

39.27

mmol/mol

0.02

1707

20737

(3014111) Lactate [Moles/volume] in Serum or Plasma

442

1795

2.76

73.63

6.3

1.12

1.33

mmol/l

3.48

436

1763

(3000991) Gas panel - Venous blood

412

1661

2.76

69.34

7.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2044

23342

0.41

66.39

5.1

6.3

2.84

2.77

mmol/l

2.98

1842

21646

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

16.51

65.12

2.0

2.8

1.75

0.72

3.29

(3020779) Urea [Moles/volume] in Serum or Plasma

404

1664

2.69

64.95

8.3

6.5

7.56

9.95

mmol/l

12.66

397

1577

(3045788) Cell count panel - Pleural fluid

127

7.56

64.60

1.2

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

196

525

3.96

64.47

2.6

3.6

0.36

0.40

iu/ml

0.55

305

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2003

22990

0.43

62.44

4.5

5.5

4.87

4.81

mmol/l

1.58

1816

21375

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1985

22855

0.44

62.08

4.5

5.4

1.58

1.60

mmol/l

1.70

1786

21109

(3020630) Protein [Mass/volume] in Serum or Plasma

425

1858

2.54

60.20

6.2

1.5

64.43

66.70

g/l

7.35

404

1653

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1517

10954

1.93

56.14

6.6

5.3

1.19

1.22

mmol/l

46.22

1440

9900

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

662

10733

0.49

54.82

1.9

2.0

1.42

1.32

mmol/l

2.79

569

8938

(3005532) Lymphocytes/Leukocytes in Pleural fluid

15.60

49.48

1.3

67.76

56.14

0.81

(3015377) Calcium [Moles/volume] in Serum or Plasma

1229

8549

1.83

48.41

5.7

2.1

2.36

2.37

mmol/l

2.37

1162

7510

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2014

22784

0.48

47.83

5.1

5.6

5.89

5.88

mmol/l

0.09

1822

20874

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1119

7633

1.82

46.40

3.8

2.4

59.28

58.84

u/l

0.05

1061

6948

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1625

12397

1.83

46.33

7.0

5.8

1.19

1.23

mmol/l

51.82

1468

10621

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2136

17828

2.12

46.30

13.0

5.8

89.51

76.61

u/l

14.88

2068

16578

(3013826) Glucose [Moles/volume] in Serum or Plasma

1741

13574

1.86

46.16

5.9

4.2

6.70

6.62

mmol/l

1.25

1682

12761

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2004

22596

0.50

42.89

6.0

6.3

2.09

1.94

mu/l

1.96

1831

20978

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

198

697

2.99

42.12

1.9

1.8

2.02

1.38

ug/l

0.49

190

601

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1909

21824

0.53

41.72

3.9

4.5

1.30

1.26

mmol/l

1.77

1695

19870

(40758558) Short blood count panel - Blood

1013

6882

1.77

41.21

16.1

4.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1959

16149

1.87

39.96

6.2

5.3

1045.67

3641.17

e6/l

2.43

197

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

157

498

3.29

39.82

1.5

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1684

13347

1.75

38.35

6.7

4.5

0.02

0.01

estimate

0.25

350

2541

(3026008) Bacteria identified in Urine by Culture

1237

9015

1.71

38.31

3.7

3.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1062

7479

1.71

36.88

7.0

2.6

33.78

29.36

u/l

0.91

1016

6976

(3035880) pH of Pleural fluid

8.65

36.16

1.2

1.1

7.37

7.50

3.18

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

324

1627

2.13

32.05

1.5

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

31.31

1.1

0.0

—

(40768793) Breast Pathology biopsy report

250

3.86

31.11

1.4

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1164

8660

1.62

31.00

5.8

3.9

167.26

122.32

e6/l

0.32

786

5769

(3002582) Erythrocytes [#/volume] in Urine

1018

7351

1.63

30.44

3.4

3.3

42.68

50.17

e6/l

0.29

754

5484

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

240

3.85

29.68

3.1

1.4

0.18

0.35

nmol/l

3.41

189

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

142

509

2.89

29.14

2.1

2.0

1397.35

4216.66

u/l

1.01

224

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

225

1042

2.27

27.07

1.7

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

565

3587

1.74

27.05

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

429

2526

1.84

26.48

2.7

2.1

7.19

6.27

umol/l

0.41

364

2137

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1760

20011

0.63

25.48

5.1

15.08

14.87

pmol/l

2.81

1597

18390

(3030467) Casts [#/volume] in Urine by Automated count

878

6365

1.57

24.44

3.2

0.56

0.43

e6/l

0.67

611

4584

(3003458) Phosphate [Moles/volume] in Serum or Plasma

448

2752

1.76

23.79

4.8

4.7

1.01

1.04

mmol/l

1.48

419

2464

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

213

1040

2.14

22.42

8.9

8.8

15.27

15.79

2.50

202

995

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

491

3146

1.69

22.26

2.3

2.6

20.91

21.24

0.23

466

2869

(3015736) pH of Urine

1315

10561

1.50

22.00

6.3

3.9

6.40

6.29

2.49

717

5753

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

21.90

1.0

0.0

—

(3018418) pH of Serum or Plasma

990

7508

1.52

21.82

3.6

3.3

7.40

1.41

606

5297

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

988

12454

0.67

21.24

2.3

2.6

77.25

80.61

nmol/l

3.37

899

11126

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

363

2170

1.78

20.99

2.1

2.2

280.76

39.21

u/l

0.50

303

1815

(3004809) Band form neutrophils/Leukocytes in Blood

219

3.40

20.28

2.7

2.3

2.08

1.05

1.52

185

(3035350) Ketones [Presence] in Urine by Test strip

1579

13278

1.48

20.23

7.0

4.4

0.00

3.96

estimate

2.01

348

2670

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

302

3.02

20.18

1.3

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

430

2726

1.69

20.11

1.7

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1558

13084

1.48

19.97

7.0

4.4

0.00

estimate

0.50

333

2540

(3004789) Transferrin [Mass/volume] in Serum or Plasma

518

3464

1.62

19.61

2.4

2.5

2.20

2.39

g/l

10.17

488

3157

(3011397) Hemoglobin [Presence] in Urine by Test strip

851

6384

1.50

19.14

6.8

4.3

0.40

0.22

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

581

4024

1.57

18.89

3.1

2.8

1.90

1.41

e6/l

0.83

291

2131

(3045142) Bone marrow Pathology biopsy report

4.83

18.48

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

134

586

2.36

18.39

2.1

3.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

551

3791

1.58

18.37

2.4

2.5

12.09

12.69

umol/l

0.86

526

3481

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

514

3502

1.58

17.82

3.2

2.9

4.80

4.75

e6/l

0.03

229

1599

(3021447) Carbon dioxide [Partial pressure] in Venous blood

350

2170

1.71

17.63

3.4

3.3

5.77

5.85

kpa

0.75

343

2126

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

14.88

17.12

1.1

1.2

1196.45

2.26

ug/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

396

2561

1.64

16.94

1.8

—

(3027945) Reticulocytes/Erythrocytes in Blood

361

2280

1.68

16.93

2.1

2.03

1.84

2.31

335

1973

(3039000) Anion gap in Blood by calculation

102

410

2.55

16.82

5.2

7.0

11.20

11.09

mmol/l

0.11

361

(3018572) Chloride [Moles/volume] in Blood

102

410

2.55

16.82

5.2

7.0

104.52

104.33

mmol/l

0.13

361

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

3.78

16.74

2.7

2.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

730

5442

1.48

16.44

1.8

1.7

2.01

1.09

mg/l

8.38

630

4200

(3029937) Albumin [Presence] in Urine by Test strip

933

7302

1.43

16.19

6.8

4.7

0.00

estimate

0.13

314

2429

(3007853) Bacteria identified in Skin by Aerobe culture

385

2508

1.63

15.94

1.6

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

233

1324

1.83

15.79

1.5

1.7

—

(3002032) Base excess in Venous blood by calculation

333

2105

1.67

15.50

3.5

3.3

2.40

2.10

mmol/l

0.66

297

1894

(3009214) Lutropin [Units/volume] in Serum or Plasma

264

2.86

15.41

1.9

1.3

21.55

17.09

u/l

1.38

208

(3019069) Monocytes/Leukocytes in Blood

1270

10557

1.40

15.34

6.7

6.0

8.67

8.62

0.19

1188

9747

(3017181) Myelocytes/Leukocytes in Blood

308

1934

1.67

14.68

3.4

3.9

1.27

0.54

5.14

156

357

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

411

2.41

14.33

1.1

1.2

—

(3001604) Monocytes [#/volume] in Blood

1371

11632

1.38

14.17

7.1

5.7

0.56

e9/l

0.03

1155

9872

(42870588) Differential panel, method unspecified - Blood

944

7535

1.40

14.14

6.7

5.6

—

(3014051) Protein [Presence] in Urine by Test strip

895

7087

1.40

14.03

5.4

3.2

0.06

0.04

0.10

213

(3037121) Protein [Mass/volume] in Urine

141

706

2.05

13.88

6.7

2.5

147.05

335.22

mg/l

4.34

198

(3000963) Hemoglobin [Mass/volume] in Blood

2367

24608

0.56

13.80

47.5

21.8

122.00

132.32

g/l

229.81

2346

24310

(3024354) Oxygen [Partial pressure] in Venous blood

296

1870

1.66

13.75

3.2

2.8

4.28

4.46

kpa

0.79

289

1827

(3019198) Lymphocytes [#/volume] in Blood

1397

11928

1.37

13.67

7.2

5.8

1.78

1.90

e9/l

0.61

1204

10381

(3000850) Epithelial cells [#/volume] in Urine

676

5116

1.43

13.62

2.7

10.52

7.54

e6/l

0.62

624

4621

(3010813) Leukocytes [#/volume] in Blood

2367

24602

0.57

13.59

47.1

21.7

6.77

6.56

e9/l

2.88

2311

23922

(3013115) Eosinophils [#/volume] in Blood

1410

12064

1.37

13.58

7.3

5.9

0.16

0.19

e9/l

11.46

1199

10419

(3026361) Erythrocytes [#/volume] in Blood

2367

24601

0.57

13.55

47.1

21.6

4.12

4.41

e12/l

139.06

2313

23929

(3006315) Basophils [#/volume] in Blood

1371

11682

1.37

13.53

7.1

5.8

0.04

e9/l

2.99

1155

9907

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2367

24599

0.57

13.48

47.0

21.6

91.89

91.20

9.53

2345

24297

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2367

24599

0.57

13.48

47.6

21.9

37.07

39.62

144.24

2345

24288

(3035941) MCH [Entitic mass]

2367

24599

0.57

13.48

46.9

21.6

30.23

30.19

0.48

2345

24297

(3002030) Lymphocytes/Leukocytes in Blood

1280

10799

1.37

13.40

6.7

5.9

25.52

28.79

17.32

1215

10098

(3007461) Platelets [#/volume] in Blood

2367

24596

0.57

13.38

47.1

21.7

273.20

260.67

e9/l

12.26

2320

24035

(3012544) pH of Venous blood

331

2183

1.59

12.89

3.4

7.39

7.38

0.68

171

1225

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

176

976

1.86

12.88

4.1

4.6

1.56

1.54

0.08

167

920

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

431

3023

1.51

12.72

9.8

6.5

—

(3023520) Reticulocytes [#/volume] in Blood

275

1752

1.64

12.32

2.0

2.1

71.71

71.13

e9/l

0.07

161

1269

(3007930) Methemoglobin/Hemoglobin.total in Blood

163

898

1.87

12.18

4.2

4.8

0.86

0.88

0.18

154

845

(1761868) Lipid panel - Serum or Plasma

647

8237

0.71

11.97

3.1

3.4

—

(3006504) Eosinophils/Leukocytes in Blood

1241

10536

1.34

11.92

6.7

5.9

2.30

2.92

23.48

1160

9724

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

10.56

11.75

1.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

361

2488

1.52

11.51

1.5

1.6

—

(3018010) Neutrophils/Leukocytes in Blood

1245

10619

1.33

11.39

6.7

5.8

59.20

56.72

7.85

1187

10022

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1663

18329

0.74

11.35

3.9

4.8

16.83

12.71

mm/h

16.65

1536

17088

(3047181) Lactate [Moles/volume] in Blood

121

618

2.00

11.32

5.2

5.9

1.33

1.25

mmol/l

0.30

105

538

(3026782) Osmolality of Urine

560

4218

1.42

11.29

3.4

2.9

486.71

490.79

mosm/kgh2o

0.18

499

3638

(40768795) Lymph node Pathology biopsy report

5.75

11.00

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

163

2.98

11.00

1.5

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

397

5437

0.68

10.93

1.3

1.4

37.67

32.53

iu/ml

0.27

124

1742

(3022096) Basophils/Leukocytes in Blood

1235

10567

1.32

10.85

6.8

6.0

0.63

0.70

5.34

1155

9734

(40760892) CBC W Ordered Manual Differential panel - Blood

633

4903

1.38

10.77

5.9

4.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

134

722

1.90

10.75

1.6

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

283

1882

1.57

10.57

2.5

2.4

0.37

0.38

e6/l

0.09

268

1779

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

151

3.02

10.54

2.0

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1001

11778

0.76

10.49

2.1

2.2

93.95

99.97

pmol/l

3.51

560

5452

(40768441) Liver Pathology biopsy report

117

3.28

10.26

1.3

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

375

5133

0.69

10.19

1.3

13.44

14.24

u/ml

0.07

143

1964

(3021589) Normoblasts [#/volume] in Blood

1190

10194

1.31

10.10

16.6

9.8

0.01

0.00

e9/l

2.30

951

8286

(21494434) Karyotype in Bone marrow

3.64

9.81

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

137

772

1.82

9.57

1.7

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

187

1195

1.61

8.28

2.9

2.6

1.30

1.16

0.96

187

1187

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

264

1825

1.50

8.22

5.7

2.3

59.92

65.25

ml/min/173m2

1.82

139

754

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

187

1197

1.61

8.22

2.9

2.6

0.64

0.62

0.31

187

1192

(3021879) Hepatitis B virus core Ab [Presence] in Serum

192

1240

1.59

8.14

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

308

2203

1.45

8.07

3.5

3.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

160

2.59

7.35

3.3

2.2

55.24

59.38

0.45

132

(3004119) Hemoglobin [Mass/volume] in Venous blood

209

1409

1.53

7.34

2.7

2.8

118.23

128.43

g/l

9.40

203

1366

(3012516) Albumin [Mass/volume] in Urine

699

8350

0.78

7.30

3.6

3.3

74.37

31.21

mg/l

5.30

436

4725

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

353

2.04

7.27

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

264

1884

1.45

7.00

3.7

4.0

0.24

0.05

3.51

111

307

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.46

6.91

1.4

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1058

9219

1.25

6.90

3.7

3.9

23.29

82.45

ng/l

1.18

807

6339

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

745

6241

1.27

6.79

2.1

2.5

2.97

2.79

mg/l

1.01

654

5418

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

6.10

6.76

6.7

1.3

56.33

80.71

ug/l

0.26

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1119

9835

1.24

6.69

6.2

4.4

0.04

0.20

estimate

1.21

273

2040

(3017143) Hepatitis C virus Ab [Presence] in Serum

269

1945

1.43

6.64

1.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

500

6166

0.77

6.55

1.3

0.93

1.71

u/ml

1.99

150

1599

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

6.19

6.46

1.3

2.5

4.25

5.50

ug/l

0.33

(3025159) Blasts/Leukocytes in Blood

264

1918

1.42

6.35

3.9

4.2

0.28

0.03

0.65

103

293

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

635

5259

1.27

6.29

3.4

2.3

2.50

2.46

mmol/l

14.39

579

4685

(3020682) Albumin/Creatinine [Ratio] in Urine

725

8492

0.80

6.13

4.2

4.0

14.20

6.65

mg/mmol

4.86

447

4720

(3009508) Creatinine [Moles/volume] in Urine

746

8664

0.80

5.74

3.5

3.3

6.27

6.26

mmol/l

0.04

628

7216

(3002179) Metamyelocytes/Leukocytes in Blood

254

1870

1.40

5.67

3.7

0.94

0.45

2.61

114

358

(36660697) Celiac disease serology panel - Serum

154

2233

0.67

5.48

1.1

1.2

—

(3000492) Spirometry study

149

2170

0.67

5.42

1.6

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

16.05

5.41

1.3

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

630

5305

1.25

5.30

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

114

728

1.59

5.16

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

388

1.80

5.01

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

388

1.80

5.01

1.2

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2336

23989

0.74

4.90

22.6

10.9

22.87

22.95

u/l

0.11

2292

23108

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

119

1762

0.66

4.72

2.2

2.4

41.95

26.10

au/ml

0.57

162

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2363

24205

0.73

4.59

39.9

18.5

71.03

70.75

umol/l

0.21

2337

23866

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

193

2599

0.72

4.54

1.7

1.6

—

(3022475) Manganese [Moles/volume] in Blood

6.69

4.46

1.4

1.0

0.15

umol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

247

3196

0.75

4.46

4.4

5.4

31.86

33.83

1.92

155

2054

(3014891) Appearance of Pleural fluid

5.24

4.45

1.6

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

109

1621

0.66

4.43

1.2

1.3

27.65

50.02

au/ml

—

102

(3019150) Specific gravity of Urine by Refractometry

699

6050

1.21

4.42

5.5

4.8

1.02

1.52

kg/l

0.80

508

3990

(3003181) Sodium [Moles/volume] in Urine

520

1.64

4.37

1.3

1.4

59.30

60.31

mmol/l

0.09

419

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

451

1.68

4.36

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

281

1.87

4.33

1.4

1.3

—

(3026726) Creatinine [Moles/volume] in Specimen

8.91

4.28

1.0

4.6

51.88

412.44

umol/l

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

713

8126

0.83

4.22

2.3

2.2

151.77

197.55

u/l

0.87

675

7619

(1175426) CD3 cells/Lymphocytes in Blood

2.57

4.21

1.9

1.8

76.26

73.00

0.61

(3014765) Yersinia sp identified in Stool by Organism specific culture

106

702

1.53

4.16

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

147

2039

0.70

4.14

2.1

2.0

3.28

3.24

ratio

0.21

114

1581

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

105

695

1.53

4.13

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

1478

0.66

4.11

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

313

3883

0.78

4.11

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

858

7617

1.19

4.06

3.2

3.1

1177.28

1155.25

ng/l

0.04

768

6524

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

147

2029

0.71

4.02

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

431

1.67

4.01

1.8

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

106

709

1.52

3.99

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

253

1972

1.31

3.94

2.5

3.45

6.34

ug/l

5.73

221

1688

(3028626) Oxygen [Partial pressure] in Capillary blood

449

1.64

3.93

2.6

3.1

8.00

8.12

kpa

0.27

439

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

817

0.56

3.91

1.6

1.7

8.00

4.07

mg/l

0.63

618

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

106

2.37

3.90

5.1

1.1

86.66

95.69

u/ml

—

(3045424) Erythrocytes [Presence] in Urine

169

1246

1.38

3.81

4.9

2.1

0.00

estimate

0.50

408

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

8.77

3.77

1.1

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

134

1853

0.71

3.72

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

433

1.63

3.70

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

624

1.53

3.69

2.9

3.3

1.78

1.44

index

0.30

283

(3020876) Protein [Mass/time] in 24 hour Urine

210

1.92

3.68

1.9

1.8

0.93

0.98

g/24h

0.08

102

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

127

901

1.43

3.58

1.6

1.93

1.62

g/l

1.84

103

778

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

422

1.63

3.56

1.3

—

(40761536) Microorganisms panel - Urine sediment

229

1788

1.31

3.54

8.3

4.3

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.05

3.53

2.3

2.4

44.00

48.72

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

10.02

3.49

1.7

1.3

175.67

328.33

umol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1315

0.67

3.40

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.40

3.39

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.63

3.30

1.7

2.3

0.65

0.81

e9/l

0.59

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.59

3.26

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

217

0.32

3.19

1.1

1.5

87.43

89.24

ng/l

—

217

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

108

1499

0.71

3.10

1.7

1.8

3.48

3.49

mmol/l

0.05

1050

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

152

1999

0.75

3.10

1.4

1.6

1.38

0.01

130

1747

(3007164) IgA [Mass/volume] in Serum or Plasma

430

4991

0.83

2.97

1.5

1.3

2.12

2.32

g/l

2.21

259

2791

(3008536) Aspergillus sp Ab [Presence] in Serum

4.72

2.92

1.1

1.0

—

(3021901) Oxygen saturation in Capillary blood

384

1.58

2.84

2.5

3.1

89.14

90.17

0.53

376

(3049717) Cytology report of Urine Cyto stain

505

1.50

2.83

2.9

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

279

1.66

2.71

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

318

3760

0.82

2.67

1.4

518.16

574.14

titre

0.29

914

(3019309) Folate [Moles/volume] in Red Blood Cells

386

4481

0.84

2.66

1.8

1.7

1232.59

1195.62

nmol/l

0.31

280

3354

(3035637) Corticotropin [Mass/volume] in Plasma

228

1.72

2.63

1.2

1.5

29.07

20.79

ng/l

0.88

228

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

162

1.86

2.62

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

593

0.58

2.61

1.0

1.2

1.62

g/l

0.02

593

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

214

1.74

2.59

1.4

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1130

0.70

2.59

1.8

—

(3008898) HLA-B27 [Presence]

799

0.64

2.58

1.1

—

(1002224) Polysomnography panel

953

0.67

2.57

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

156

1988

0.77

2.57

1.2

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

211

1704

1.26

2.56

5.7

3.1

4.39

4.48

pmol/l

0.83

198

1497

(3003327) Ova and parasites identified in Stool by Light microscopy

893

0.66

2.56

1.6

1.7

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.74

2.54

2.3

2.0

31.67

24.98

0.98

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1239

13190

0.88

2.53

2.7

2.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

115

2.01

2.50

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

1.73

2.50

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

462

1.48

2.49

1.4

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2322

22704

1.22

2.44

24.5

13.9

35.69

20.65

mg/l

68.72

2158

18262

(3051387) C reactive protein [Mass/volume] in Capillary blood

489

1.46

2.44

4.3

3.8

32.63

23.26

mg/l

1.04

345

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.13

2.36

1.9

1.2

166.86

3656.50

u/l

—

(3042631) Mycobacterium sp identified in Specimen

229

1.67

2.33

2.3

3.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

129

1657

0.77

2.28

1.3

214.40

173.83

u/ml

0.24

116

1527

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.03

2.26

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

106

1.99

2.25

1.5

2.2

7.57

8.89

mmol/l

0.91

106

(3020393) Adenovirus Ag [Presence] in Stool

3.90

2.25

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

3.90

2.25

1.0

1.1

—

(1616796) Gas panel - Central venous blood

391

1.49

2.24

3.1

3.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

143

1122

1.29

2.23

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1061

11332

0.89

2.17

2.9

3.1

181.23

92.73

ug/l

15.90

999

10497

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

362

1.50

2.15

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

414

1.46

2.09

3.7

3.1

62.50

57.68

1.73

414

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.01

2.07

1.8

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

103

1.95

2.05

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

541

0.62

2.04

1.5

2.1

4.22

5.01

mmol/24h

1.01

464

(3041096) Erythrocytes [Presence] in Urine by Automated

735

6733

1.13

2.04

5.6

3.7

1.85

0.54

estimate

0.49

273

2020

(3035715) Granulocytes [#/volume] in Blood

351

1.49

2.02

3.9

3.3

4.61

3.94

e9/l

0.72

351

(40768797) Stomach Pathology biopsy report

317

3653

0.85

2.01

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

347

1.48

1.92

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

151

1220

1.25

1.89

1.8

1.5

1.27

1.29

g/l

0.04

136

1108

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1201

0.76

1.88

1.3

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

585

1.36

1.88

5.2

4.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

505

0.63

1.87

1.7

292.30

336.79

mu/l

0.54

450

(3014133) Dog dander IgE Ab [Units/volume] in Serum

264

0.49

1.85

1.0

1.1

0.41

3.98

u/ml

—

118

(3002619) Bacteria identified in Specimen by Culture

2.21

1.84

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

297

3405

0.86

1.78

1.7

2.1

134.48

119.95

ug/g

0.28

237

2663

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

1.84

1.77

1.3

—

(3013512) EKG study

832

8927

0.90

1.75

4.2

3.6

—

0.87

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2158

22033

0.88

1.71

30.6

13.4

78.16

77.20

ml/min/173m2

1.44

2028

20256

(44816559) Phosphatidylethanol [Mass/volume] in Blood

714

0.71

1.67

1.5

1.4

0.40

0.32

mg/l

0.38

266

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

309

1.46

1.66

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

677

0.70

1.64

1.4

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.25

1.63

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.84

1.61

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.84

1.61

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

161

1927

0.82

1.60

1.2

104.77

130.46

u/ml

0.45

750

(44790049) Parainfluenza type 3 nucleic acid detection

231

1.52

1.57

1.5

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

231

1.52

1.57

1.5

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

231

1.52

1.57

1.5

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

231

1.52

1.57

1.5

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

129

1.71

1.56

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1056

0.77

1.56

1.5

1.6

7.80

16.72

u/ml

3.14

213

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

298

0.57

1.55

1.4

1.5

1.01

0.95

ratio

—

187

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

298

0.57

1.55

1.4

1.5

1.00

1.16

ratio

—

187

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

298

0.57

1.55

1.4

1.5

0.99

1.23

ratio

—

187

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

321

0.59

1.52

1.5

54.06

61.49

ug/l

0.42

263

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

1.51

0.0

2.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

0.40

1.49

1.8

2.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

1.49

0.0

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

106

1314

0.80

1.49

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

698

0.73

1.49

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

294

0.58

1.49

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.37

1.45

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

148

1.63

1.44

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

352

0.62

1.43

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

179

0.50

1.39

1.1

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

179

0.50

1.39

1.1

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

133

1102

1.22

1.39

3.8

3.4

2.46

2.21

mmol/l

0.29

103

845

(3024869) Neuronal Ab [Presence] in Serum

2.42

1.39

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

337

0.62

1.39

1.6

56.29

58.46

0.10

200

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

454

0.68

1.35

2.5

2.3

341.97

64.87

ug/min

0.47

258

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

222

0.54

1.35

1.0

1.1

0.12

0.13

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

151

1.59

1.34

1.1

1.2

—

(4024509) Urine culture

122

1471

0.82

1.34

2.5

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

418

0.67

1.34

1.0

1.1

0.80

1.61

u/ml

0.97

227

(3010726) Horse dander IgE Ab [Units/volume] in Serum

296

0.61

1.32

1.0

1.1

1.20

1.30

u/ml

—

141

(3005719) IgG [Mass/volume] in Serum or Plasma

181

1552

1.18

1.32

2.8

2.7

9.77

10.51

g/l

1.37

168

1428

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

765

1.25

1.31

1.2

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.10

1.30

1.1

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

301

1.40

1.29

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

133

0.45

1.28

1.0

1.2

—

(3009343) pH of Capillary blood

151

1279

1.19

1.28

3.8

3.5

7.42

0.56

129

1051

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.09

1.27

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

336

1.38

1.27

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

130

1.62

1.26

2.0

1.7

70.81

75.13

umol/l

0.35

130

(3021788) Differential panel - Synovial fluid

494

0.70

1.26

1.3

1.5

—

1.00

—

(3025941) Bacteria identified in Stool by Culture

152

1290

1.19

1.26

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

654

0.74

1.25

1.6

15234.74

9736.78

e6/l

0.55

449

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

776

0.77

1.23

1.4

1.5

0.04

0.08

iu/ml

0.50

147

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.00

1.23

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1521

14705

1.08

1.23

4.3

3.1

58.02

40.14

u/l

8.93

1423

13589

(3017732) Neutrophils [#/volume] in Blood

335

3024

1.12

1.20

8.3

2.8

5.49

4.36

e9/l

0.62

305

2576

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

164

1.53

1.20

1.4

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

671

0.76

1.20

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

272

1.40

1.19

1.2

1.4

143.91

160.20

au/ml

0.33

(3051611) Lipemic interference index of Serum or Plasma

222

1.45

1.19

2.9

3.4

11.30

14.55

index

1.43

(3023430) Cat dander IgE Ab [Units/volume] in Serum

248

0.60

1.16

1.0

1.1

0.75

4.47

u/ml

—

101

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

182

1.49

1.15

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

811

0.78

1.14

1.4

257.88

301.04

ug/g

1.04

471

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

1.14

0.0

1.1

—

0.04

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

1.14

0.0

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

1.14

0.0

1.1

—

9.16

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

529

0.73

1.13

1.5

1.6

922.76

970.59

mu/l

0.19

438

(3032773) Endomysium IgG Ab [Titer] in Serum

260

1.39

1.09

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.38

1.09

1.4

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

375

0.69

1.09

1.6

0.96

0.67

g/l

0.18

291

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

292

0.65

1.09

1.3

—

47.80

—

(3004451) EKG impression Narrative

136

1.55

1.08

1.3

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

397

0.70

1.07

1.1

66.54

23.79

au/ml

—

(40767503) Oxygen content in Capillary blood by calculation

392

1.31

1.05

2.2

2.8

15.02

16.35

2.66

386

(3043238) Trisomy 21 risk [Likelihood] in Fetus

253

0.63

1.05

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

504

4686

1.09

1.04

4.1

3.9

52.62

274.03

ng/l

4.91

409

3582

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.96

1.03

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

323

0.68

1.02

1.0

1.1

0.34

0.92

u/ml

—

135

(40768443) Skin Pathology biopsy report

1071

0.82

1.02

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1179

0.83

1.01

1.6

1.9

1.38

7.12

iu/ml

13.76

288

(4146454) Self-monitoring of blood glucose

274

0.65

1.00

3.2

2.7

—

(4034850) Laboratory test

792

1.21

1.00

12.4

9.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

333

0.69

1.00

1.3

1.2

—

(3036603) Volume of Urine

172

1.46

0.99

1.4

1.5

1770.16

1869.54

0.24

167

(3017569) Oxygen content in Arterial blood

115

1.57

0.99

1.9

2.5

13.96

15.75

2.58

115

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

126

1465

0.85

0.98

1.9

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1153

0.84

0.98

1.2

1.3

0.50

1.12

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.18

0.98

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

117

997

1.18

0.98

1.7

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

292

1.34

0.98

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

187

0.59

0.97

1.5

1.3

7.46

8.10

mmol/l

0.30

179

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

247

0.65

0.96

1.4

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

833

0.81

0.94

3.5

1.4

0.87

0.31

g/l

0.83

704

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.77

0.94

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

294

1.33

0.94

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

982

0.83

0.91

3.0

1.4

7.45

7.60

g/l

0.36

873

(3003329) Lymphocytes/Leukocytes in Synovial fluid

232

0.64

0.91

1.4

1.6

41.52

36.62

—

136

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

981

0.83

0.91

3.0

1.4

3.40

3.65

g/l

1.58

872

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.60

0.90

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

243

0.66

0.90

1.4

1.50

1.27

—

170

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

980

0.83

0.90

3.0

1.4

4.16

4.31

g/l

1.12

871

(3005988) Vibrio sp identified in Specimen by Organism specific culture

297

1.32

0.89

1.3

—

(3017704) Immunofixation for Urine

104

0.48

0.89

1.4

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

128

0.55

0.88

1.4

1.3

5.82

mmol/l

—

121

(3040151) Glucose [Moles/volume] in Capillary blood

246

1.35

0.87

1.9

3.9

8.21

7.05

mmol/l

0.61

206

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

316

1.30

0.87

1.2

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

853

0.83

0.84

2.6

1.4

9.56

9.95

g/l

0.32

732

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

222

1.36

0.83

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

331

0.72

0.83

1.0

1.1

2.29

2.76

u/ml

—

166

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

146

1.44

0.82

1.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

146

1.44

0.82

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

146

1.44

0.82

1.4

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.70

0.82

2.5

2.8

10.09

9.95

kpa

0.10

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.70

0.82

2.5

2.8

4.80

5.23

kpa

0.75

(3020717) Zinc [Moles/volume] in Serum or Plasma

155

1.42

0.81

2.0

1.3

45.08

22.48

umol/l

1.85

138

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

1.9

—

1.40

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

187

0.64

0.78

3.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

313

1.28

0.78

1.2

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

322

1.28

0.77

1.2

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.77

0.0

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.00

0.77

0.0

8.1

—

10.09

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

8.89

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

203

2241

0.90

0.77

3.2

81.16

82.57

ng/l

0.08

181

1877

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

920

0.84

0.77

3.1

1.4

3.12

2.90

g/l

1.10

811

(3019174) dRVVT (LA screen)

0.00

0.76

0.0

1.3

—

(3045414) Leukocytes [Presence] in Urine

291

2683

1.10

0.76

4.0

2.2

0.05

0.01

estimate

0.50

516

(3023419) Bacteria identified in Sputum by Culture

270

1.30

0.76

2.3

2.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.09

0.74

1.2

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

0.74

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

243

0.70

0.74

1.4

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

202

1.34

0.72

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

142

1.41

0.72

1.1

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

145

1624

0.89

0.72

2.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

317

1.27

0.72

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

129

1455

0.88

0.72

2.3

2.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.55

0.72

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.55

0.72

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

653

0.82

0.71

1.1

2.55

8.18

eliau/ml

—

(3022145) Colonoscopy Study observation

286

2645

1.09

0.71

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.92

0.70

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

610

1.19

0.70

3.0

3.6

0.73

0.84

nmol/l

2.28

505

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

286

0.73

0.70

1.1

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

143

0.63

0.69

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

308

0.74

0.69

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

266

1.28

0.68

1.2

1.1

—

0.39

—

(3003740) Influenza virus B Ag [Presence] in Specimen

307

0.75

0.68

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

0.59

0.67

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.53

0.66

2.6

1.1

39.00

40.01

g/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

522

1.19

0.65

4.9

2.9

1.58

1.59

mg/l

0.04

454

(3023323) Follitropin [Units/volume] in Serum or Plasma

115

1017

1.14

0.65

1.7

1.3

35.99

34.41

iu/l

0.20

901

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

180

1.34

0.65

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

178

0.67

0.64

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

496

1.19

0.64

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

381

0.78

0.63

1.4

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

111

983

1.13

0.63

1.3

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

104

1.44

0.62

1.3

1.5

2.85

3.84

umol/l

0.72

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

102

0.59

0.62

2.7

2.5

—

34.00

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

105

0.57

0.61

1.0

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

156

1.35

0.61

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

175

0.68

0.60

1.6

1.5

80.64

54.52

ug/l

0.51

175

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.60

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.60

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.60

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

574

1.17

0.60

1.1

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

593

1.17

0.59

1.2

1.3

257.65

230.91

miu/ml

0.21

291

(3012501) Base excess in Blood by calculation

381

1.21

0.59

3.4

3.38

2.61

mmol/l

1.01

269

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.7

—

(3024263) Appearance of Synovial fluid

115

0.61

0.57

1.0

1.6

—

(3044941) Cell count panel - Synovial fluid

452

0.82

0.57

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

296

2774

1.08

0.56

1.6

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.46

0.56

2.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

541

1.17

0.56

1.9

2.2

121.00

127.35

g/l

1.62

419

(44806420) Estimation of glomerular filtration rate

274

0.76

0.55

2.4

2.5

—

(3022621) pH of Urine by Test strip

194

2100

0.92

0.54

2.9

3.0

5.96

6.09

1.36

139

1439

(40757373) Influenza virus identified in Isolate

1.58

0.54

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

675

0.86

0.54

3.0

1.4

0.00

g/l

-0.00

589

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

227

0.75

0.53

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

169

1.30

0.53

2.0

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

734

7599

0.95

0.53

1.8

1.7

20.05

21.60

nmol/l

2.15

661

6288

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.45

0.53

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.43

0.52

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

0.60

0.51

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

303

0.79

0.51

1.0

1.1

1.63

3.77

eliau/ml

1.04

119

(3006653) Thiamine [Moles/volume] in Blood

109

1.38

0.51

1.4

1.3

142.93

128.23

nmol/l

0.35

109

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1892

18673

1.05

0.50

36.9

17.0

14.50

13.57

107.82

1880

18387

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.50

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.50

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.50

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.50

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.39

0.50

1.1

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.46

0.50

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

213

0.75

0.50

1.0

1.2

1.91

1.18

u/ml

0.16

113

(21494890) Protein electrophoresis panel - 24 hour Urine

171

1.29

0.49

1.8

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

240

2245

1.08

0.49

3.0

1.8

459.28

373.49

nmol/l

5.49

230

2042

(3025130) Human papilloma virus identified in Specimen

455

1.17

0.49

1.5

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

201

0.74

0.49

1.0

39.63

48.73

ng/l

—

133

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.37

0.48

1.5

2.1

92.40

100.49

0.38

(40759836) Histone Ab [Presence] in Serum by Immunoblot

223

0.76

0.48

1.2

—

(3003129) Base excess in Capillary blood by calculation

245

0.77

0.48

1.4

2.1

-0.87

1.30

mmol/l

1.71

236

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.47

0.47

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.46

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.62

0.45

2.4

2.5

192.80

158.01

nmol/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

119

0.67

0.45

1.4

1.2

—

6.31

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.43

0.45

1.2

1.1

108.09

114.65

0.66

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

198

0.76

0.45

1.0

586.20

744.38

ng/l

—

125

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

302

1.19

0.44

1.2

269.48

261.97

u/ml

0.05

182

(3015235) Bicarbonate [Moles/volume] in Capillary blood

678

1.12

0.43

2.3

2.9

24.77

25.31

mmol/l

0.54

669

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

262

0.80

0.42

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

195

0.77

0.41

1.0

299.00

370.30

ng/l

—

130

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

128

1389

0.92

0.41

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

217

0.78

0.41

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

70.40

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.41

0.0

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.01

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2347

23607

0.94

0.41

33.3

17.1

3.94

3.95

mmol/l

1.18

2319

23065

(3016018) Differential panel - Cerebral spinal fluid

271

0.81

0.40

1.2

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

216

0.79

0.40

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.93

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.31

0.39

1.0

0.35

0.32

u/ml

—

(3028433) Virus identified in Specimen by Culture

1.36

0.38

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

188

1.23

0.37

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

213

0.80

0.36

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

849

0.90

0.36

1.2

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

189

1.22

0.36

1.2

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

122

0.74

0.35

1.4

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

423

1.14

0.35

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

125

0.72

0.35

1.2

—

(3044927) Protein electrophoresis panel - Urine

265

0.83

0.34

1.0

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

163

1.23

0.34

1.1

1.0

65.07

11.77

nmol/l

—

(3000494) Fungus identified in Specimen by Culture

276

2889

0.95

0.34

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

154

1.24

0.34

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

199

0.80

0.33

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

210

1.19

0.32

1.8

8.99

8.28

umol/l

0.06

145

(3032057) Clostridioides difficile [Presence] in Stool

1.28

0.32

1.3

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

137

1.24

0.32

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

295

1.15

0.31

2.8

2.2

25.00

25.80

mg/l

0.04

(3007566) Smooth muscle Ab [Titer] in Serum

657

1.10

0.31

1.1

1.2

66.25

110.75

titre

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

218

0.82

0.30

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.27

0.30

1.4

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

640

0.90

0.29

1.1

1.6

—

30.05

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.25

0.29

1.6

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2347

23573

0.95

0.28

33.6

17.0

138.91

139.83

mmol/l

49.69

2319

23079

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

205

0.83

0.28

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

116

0.78

0.27

1.0

1.7

—

(3014271) Vancomycin [Susceptibility]

120

0.75

0.27

2.3

3.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

364

0.88

0.27

1.6

1.3

—

nmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

131

1.22

0.27

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

749

0.92

0.26

3.3

1.5

49.26

38.71

mg/l

0.59

628

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.30

0.26

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.30

0.26

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.30

0.26

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.30

0.26

1.0

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

203

0.84

0.25

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

235

0.85

0.25

1.2

1.5

5.42

6.68

g/l

1.63

168

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.25

0.25

1.1

—

(3004775) Volume in Urine collected for unspecified duration

138

0.80

0.25

2.0

2.5

483.40

615.61

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

234

0.85

0.24

1.2

1.5

2.23

2.76

g/l

0.47

167

(3024139) IgG subclass 3 [Mass/volume] in Serum

234

0.85

0.24

1.2

1.5

0.51

0.36

g/l

1.08

168

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.27

0.24

1.4

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.28

0.24

1.4

1.2

30.00

10.56

mm/h

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.73

0.24

1.2

1.0

—

(3008295) Osmolality of Serum or Plasma

274

1.13

0.24

1.1

1.4

272.27

273.31

mosm/kgh2o

0.09

209

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

265

0.87

0.24

1.3

1.2

57.09

59.62

u/l

0.17

227

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

201

0.84

0.23

2.2

2.4

2.63

2.14

u/field

—

113

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

717

1.08

0.23

4.9

3.5

25.33

25.27

mmol/l

0.06

650

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

106

1.23

0.23

1.1

1975.31

1646.48

miu/ml

0.35

106

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1862

18754

0.97

0.23

40.7

18.6

328.49

330.35

g/l

18.29

1850

18661

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

897

0.93

0.22

1.3

5.75

43.97

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

438

1.10

0.22

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

295

1.12

0.22

1.5

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.22

0.22

1.8

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.19

0.21

1.2

2.0

1.20

mmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.7

—

240.91

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.0

—

0.80

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.0

—

3.20

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

585.03

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.8

—

23.69

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.23

—

(4212803) Bone marrow aspirate examination

0.00

0.21

0.0

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

749

0.93

0.20

3.3

1.5

29.40

31.16

mg/l

0.20

624

(3000034) Microalbumin [Mass/volume] in Urine

219

0.87

0.20

2.8

2.6

87.82

16.42

mg/l

0.49

143

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

490

0.92

0.20

1.2

1.3

—

(4062490) Immunoglobulin typing, IgG

229

0.87

0.20

1.2

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

288

1.11

0.20

2.0

1.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

176

0.85

0.20

1.1

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.15

0.19

3.0

2.7

0.61

0.62

mmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

405

0.91

0.18

1.1

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

587

5773

1.02

0.17

2.7

2.2

314.54

322.71

umol/l

1.18

525

4954

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.75

0.17

1.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.16

0.16

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

833

0.95

0.16

1.3

1.30

5.74

u/ml

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

111

1.17

0.15

2.3

2.6

1211.69

791.46

u/ml

0.54

111

(3016879) Cocaine [Presence] in Urine

390

0.92

0.15

1.9

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.75

0.15

8.2

2.7

32.47

27.85

umol/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

830

0.95

0.15

1.8

2.0

3.59

11.11

iu/l

0.54

329

(4268621) Lupus anticoagulant assay

236

1.10

0.14

2.3

2.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.78

0.14

2.4

2.1

—

101.38

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.81

0.13

1.3

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

837

0.95

0.13

1.3

6.48

6.96

u/ml

0.04

145

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

1.14

0.13

1.1

—

(3028300) Cannabinoids [Presence] in Urine

427

0.94

0.12

1.8

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

334

0.93

0.12

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

133

1.13

0.12

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

157

0.89

0.11

1.3

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

221

1.09

0.11

1.2

1.1

114.50

111.99

pmol/l

0.08

221

(3027944) Amphetamines [Presence] in Urine

424

0.94

0.11

1.8

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

424

0.94

0.11

1.8

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

310

1.07

0.10

1.7

1.8

2.02

1.64

mmol/l

0.83

303

(3027008) Opiates [Presence] in Urine

422

0.95

0.09

1.8

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

666

0.96

0.09

1.2

50.52

48.82

u/ml

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

145

1.10

0.09

1.4

1.2

27.81

16.55

u/l

0.51

119

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

655

0.96

0.09

3.4

1.5

3.08

1.45

ratio

0.66

382

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

604

0.96

0.09

2.4

2.1

9.86

11.57

mg/l

1.08

554

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.09

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.09

0.09

3.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

134

0.90

0.08

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.07

0.08

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

113

0.88

0.08

1.3

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

440

0.95

0.08

1.1

1.3

—

88.57

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

541

0.96

0.08

1.3

1.4

1333.38

1353.24

e6/l

0.01

429

(37208534) Antinuclear antibody arbitrary concentration in serum

0.84

0.07

1.2

1.0

—

(3019225) pH of Specimen

245

2414

1.02

0.07

3.5

3.7

7.35

7.36

0.32

190

1533

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.07

0.07

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

828

1.03

0.07

1.6

1.7

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

109

1.10

0.06

1.2

0.50

0.53

ratio

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

233

0.94

0.05

1.4

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

496

0.97

0.05

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

376

1.04

0.05

1.2

1.3

15.04

61.21

u/ml

—

(3000012) Reticulocyte production index

238

1.05

0.05

1.7

1.09

0.83

1.15

133

(3010144) Erythrocytes [#/volume] in Synovial fluid

242

0.95

0.05

1.2

1.4

45084.72

96658.50

e6/l

0.57

153

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

188

1902

0.99

0.04

3.3

3.0

1.23

1.24

mmol/l

0.24

165

1556

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

986

0.98

0.04

2.1

2.0

40.36

40.17

u/l

0.03

866

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

381

0.97

0.03

1.5

1.2

0.18

0.19

nmol/l

0.25

292

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

198

1997

0.99

0.03

2.6

3.0

189.50

176.31

ng/l

0.09

179

1825

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

340

1.03

0.03

1.1

1.2

4.17

3.60

u/ml

0.14

138

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

231

1.04

0.02

1.0

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

430

0.98

0.02

1.5

1.3

0.66

7.40

nmol/l

0.78

415

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

341

1.03

0.02

1.2

5.31

2.64

u/ml

0.31

113

(3037756) Immunofixation for Serum or Plasma

419

0.98

0.02

1.6

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

0.94

0.01

1.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

560

5588

1.00

0.01

1.6

1.7

16558270.32

35237931.21

pmol/l

0.51

459

4569

(3022313) Gas panel - Capillary blood

902

1.01

0.01

4.6

3.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

327

0.98

0.01

1.1

134.33

120.58

0.97

294

(3000330) Specific gravity of Urine by Test strip

135

1356

1.00

0.00

6.2

3.6

1.02

ratio

0.16

123

1220

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.05

0.00

1.1

31.60

163.07

ng/l

—

(3023410) Appearance of Cerebral spinal fluid

235

1.02

0.00

1.3

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

531

1.00

0.00

1.2

1.3

5.24

23.55

e6/l

1.69

397

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.04

0.00

1.1

1.6

1974.90

61.11

nmol/24h

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

206

1.02

0.00

1.0

—

(3006462) Nitrate [Presence] in Urine

112

0.98

0.00

2.9

3.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

118

1.02

0.00

1.0

0.53

0.49

u/ml

—

(3020491) Glucose [Moles/volume] in Blood

152

0.99

0.00

1.1

2.4

6.56

6.86

mmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

348

1.01

0.00

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

117

1.03

0.00

1.1

1.2

142.58

147.18

mmol/24h

0.04

117

(4211845) Urine protein measurement

123

0.98

0.00

2.7

3.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.96

-0.00

4.1

5.2

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

0.02

—

(4015189) Microbial culture of sputum

0.85

-0.00

1.6

3.2

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

3.6

—

1.16

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.07

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2915.14

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.54

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

4.9

—

321.62

—

(3033099) Centromere Ab [Titer] in Serum

0.87

-0.00

1.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

1.9

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

2.60

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(4195642) Thrombophilia screening test

320

1.00

-0.00

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

-0.00

0.0

1.9

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.91

-0.00

1.2

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_OVARY_WIDE – Malignant neoplasm of ovary, including Hilmo

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of ovary, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of ovary, including Hilmo (C3_OVARY_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints